Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
A randomised controlled trial of Reinforcement Of Closure of Stoma Site using a biological mesh
ISRCTN ISRCTN46330337
DOI 10.1186/ISRCTN46330337
ClinicalTrials.gov identifier
EudraCT number
Public title A randomised controlled trial of Reinforcement Of Closure of Stoma Site using a biological mesh
Scientific title
Acronym ROCSS
Serial number at source 13461
Study hypothesis Abdominal wall hernias are common and are a significant cause of morbidity. Incisional hernias form following closure of the abdominal wall musculature. Incisional hernias at the site of stoma closure are not an infrequent problem, occurring in up to 30% of cases. Not only are they associated with adverse effects on patient’s quality of life but in up to 10 % of cases, patients require complex reoperation associated with a high complication rate. It is for this reason that many patients choose to live with the hernia rather than undergo further surgery. Techniques that prevent the hernia from developing would improve the patient’s quality of life and reduce the costs associated with redo surgery. Repair of incisional hernia commonly employs prosthetic meshes that reinforce and aid the tissue healing process. It is inappropriate to use synthetic mesh at site of previous stomas as there has been leakage of bowel contents that would infect the mesh and further compound the healing process. Many surgeons therefore choose to close the defect with sutures rather than using mesh. This may be a contributory factor in the subsequent development of hernias. Biological mesh implants may be more suitable in these circumstances.

There is no evidence regarding the benefits of using biological mesh to prevent hernias at site of stoma closure. The balance of risks and benefits has not been reliably assessed in a randomised control trial. ROCCS is a randomised controlled trial of the placement of a biological mesh at the site of stoma closure. Our hypothesis is that reinforcing the stoma closure site with a collagen mesh (Strattice®) is superior to the standard technique in preventing herniation at 2 years.

More details can be found at: http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=13461
Lay summary Not provided at time of registration
Ethics approval 12/WM/0187
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Topic: Oral and Gastrointestinal, Generic Health Relevance and Cross Cutting Themes; Subtopic: Oral and Gastrointestinal (all Subtopics), Generic Health Relevance (all Subtopics); Disease: Gastrointestinal, Surgery
Participants - inclusion criteria Patients to be included in the study must:
1. Require an elective closure of stoma site
2. Have given written informed consent
3. Male & Female, be aged 18 or over
4. Agree to the randomised procedure
Participants - exclusion criteria 1.Patients taking part in another clinical study which directly relates to the surgical procedure
2. Allergic to any porcine or collagen products
3. Unable or unwilling to provide written informed consent
Anticipated start date 29/10/2012
Anticipated end date 29/10/2013
Status of trial Ongoing
Patient information material
Target number of participants Planned Sample Size: 90; UK Sample Size: 90
Interventions Reinforcement by collagen mesh: Reinforcement of the stoma closure site using the Strattice® collagen mesh.
Primary outcome measure(s) Recruitment at 12 months
Secondary outcome measure(s) No secondary outcome measures
Sources of funding LifeCell Corporation (USA)
Trial website
Publications
Contact name Prof  Dion  Morton
  Address Academic Department of Surgery
School of Medicine
Queen Elizabeth Hospital
Edgbaston
  City/town Birmingham
  Zip/Postcode B15 2TH
  Country United Kingdom
  Email dion.morton@uhb.nhs.uk
Sponsor University of Birmingham (UK)
  Address Edgbaston
  City/town Birmingham
  Zip/Postcode B15 2TT
  Country United Kingdom
  Sponsor website: http://www.birmingham.ac.uk
Date applied 28/11/2012
Last edited 30/11/2012
Date ISRCTN assigned 30/11/2012
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.